China Notes Sharp Decline in Vaccine Exports

---

Researched by Industrial Info Resources (Sugar Land, Texas)--China's exports of human vaccines dropped 64% during the first half of 2022 from the same period in 2021, according to news accounts, which cited data from the Huajing Industry Research Institute.

The export of human vaccines from China in the first half of the year totaled 681,997 kilograms, a drop of 1,219,171 kilograms from the first half of 2021.

By value, vaccine exports during the first half of 2022 amounted to US$846 million, a drop of US$6.6 billion, or 88.7%, from the first half of 2021.

Chinese news media have cited falling foreign demand for the drop in exports. Some media outlets attributed the decline in vaccine exports to a decline in sales due to the weak defense of Chinese vaccines against the COVID-19 Omicron variant.

IIR is tracking 14 active vaccine projects in China, with a total value of US$1.1 billion. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list detailed project reports.

These projects mainly are concentrated in the Shandong, Jiangsu and Liaoning provinces.

Click on the image at right for a graph showing vaccine project activity in China by province.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 Trillion (USD).